palli/onc Flashcards

1
Q

acanthosis palmaris

A

paraneoplastic
usually pulm or gastric origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

diagnosing AML

A

low Hb, neutrophils, platelets
raised WCC
blasts and Auer rods on film
> 20% blasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

AML treatment

A

cytarabine, idarubicin, daunorubucin
gemtuzumab ozogamicin (CD33)
midostaurin (FLT3)

supportive: hydroxycarbamide allopurinol rasburicase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

diagnosing adrenal tumours

A

CT, MRI
MIBG scan- MIBG similar to adrenaline and taken up by neuroendocrine tumour
adrenal v sampling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

adrenal tumour treament

A

alpha blockers then surgery for phaeochromocytoma

ketoconazole and metyrapone to reduce steroid
spironolactone to block aldosterone
mifepristone to block cortisol
tamoxifen to block oestrogen

mitotane for metastatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pain ladder

A
  1. paracetamol
  2. ibuprofen or weak opioid
  3. 1 + 2
  4. paracetamol + alternative NSAID
  5. paracetamol + weak opioid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pain ladder for cancer pain

A
  1. non opioid +/- adjuvant
  2. opioid +/- 1.
  3. stronger opioid +/- 1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

diagnosing aspergillosis

A

serum aspergillus galactomannan
serum 1-3 beta D glucan
halo sign (nodule), air crescent

ABPA- elevated IgE, aspergillus IgE and IgG

chronic- IgG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

bladder ca treatment

A

non muscle invasive:
CIS, Ta, T1- resection TURBT and single shot mitomycin C intravesically
greater than 3cm- 6 shots
high risk G3T1 - 2x TURBT and intravesical BCG or radical cystectomy

muscle invasive:
radical cystectomy, ileal conduit
radical RTx
neoadjuvant cisplatin

metastatic: platinum chemo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CIN staging

A

CIN1- mild dyskaryosis
CIN3- high grade, full thickness, requires surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cervical cancer staging

A

1a, 1b confined to cervix
2 extends beyond uterus but not pelvic wall or lower 1/3 vagina
3 extends to pelvic sidewall or lower 1/3 vagina or hydronephrosis
4 beyond bladder/rectum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

alkylating chemo

A

cyclophosphamide
inactivates enzymes involved in DNA production

s/e: haemorrhagic cystitis, pulm fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

antimetabolite chemo

A

interferes with purine or pyramidine synthesis
MTX (hepatic failure, pulm fibrosis)
5FU (palmar plantar syndrome, cardiotoxic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

antibiotics as chemo

A

anthracycline- doxorubicin
s/e: CCF

bleomycin
s/e: pneumonitis, fibrosis, rash

mitomycin c
s/e: kidney failure, stomatitis, rash, alopecia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

vincristine

A

inhibits spindle formation and mitosis
s/e: neuropathy, bronchospasm, blistering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

paclitaxel

A

stabilises microtubules, inhibits mitosis
s/E: sudden total alopecia, myalgia, peripheral neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

topoisomerase inhibitors

A

e.g. irinotecan
s/e: cholinergic syndrome, profuse diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

CLL cells

A

CD5, CD19, CD23 monoclonal B lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

diagnosing CLL

A

raised WCC
lymphocytosis > 5
smudge/smear cells on film
CD5, 19, 20, 23 on cytometry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

CLL treatment

A

fludrabine + cyclophosphamide + rituximab 1st line

alkylating agents, purine analogues, ibrutinib second line

allogenic SCT for TP53 after remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CML

A

BCR ABL chr 9, 22 philadelphia
mature myeloids, basophils and eosinophils on smear
granulocyte left shift

tx: tyrosine kinase inhib (imatinib)
allogenic SCT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

MRI sequences for CNS tumours

A

T1: CSF low signal (dark)
T2: CSF high signal (white)
FLAIR: for periventricular
STIR

23
Q

indications for stereotactic brain RTX

A

AVM lesions not amenable to coiling or clipping
vestibular schwannoma
mets

24
Q

indications for brain metastectomy

A

patient is fit
symptomatic lesions is accessible
good prognosis of primary

25
Q

indications for surgery for pituitary tumours

A

non functional with mass effects
cushings
acromegaly
acute visual deterioration
pituitary apoplexy

26
Q

colorectal TNM

A

to- no evidence
tis- in situ
t1- submucosa
t2- muscularis mucosa
t3- subserosa or non peritonealised tissues
t4- other organs or structures or perforates visceral peritoneum

n1- 1-3 regional nodes
n2- 4 regional nodes

adjuvant chemo for stage 3 FUFA

27
Q

colorectal cancer surgery abx prophylaxis

A

metro and cephalosporin at induction and 2 doses post op

28
Q

indication for endometrial biopsy

A

> 4mm thickness

29
Q

endometrial staging

A

FIGO
1: uterus body
2: uterus and cervix
3: beyond uterus within pelvis
4: bladder/bowel/beyond

30
Q

endometrial ca treatment

A

internal/external RTX
progesterone if still wanting to conceive
CTx stage 3-4

hysterectomy:
stage 1- hysterectomy and BSO
stage 2-3- radical hysterectomy with nodes, cervix and top of vagina
stage 4- debulking

31
Q

driving and seizures

A

inform after 1st episode
no driving for 6 months 1st seizure normal EEG
no driving for 12 months if abnormal

can drive if seizure free for 1y or nocturnal only for 3y
vocational or group 2 license requires seizure and antiepileptic meds free for 10y

32
Q

gastric ca Lauren classification

A

diffuse: poorly differentiated, aggressive
intestinal type: well differentiated and slow growing, more common in men

33
Q

first line antieplipetics

A

gen tonic clonic: valproate
focal: carbamaz
absence: ethosux

34
Q

treating gastric ca

A

resection for T1/2
gastrectomy for > t2 or > N0
adjuvant chemo
trastuzumab for HER2 metastatic adenocarcinoma
triple therapy to eradicate h pylori

35
Q

liver transplant criteria for liver ca

A

single tumour smaller than 5cm
no vasc or metastatic spread
AFP < 1000

36
Q

treatment for cholangiocarcinoma

A

resection or transplant if unresectable at presentation
capecitabine post resection

CTx if inoperable:
Gem/Cis
FOLFOX second line

palliative stenting to relieve jaundice

37
Q

diagnosing and treating hodgkins lymphoma

A

raised neutrophils, platelets, eosinophils, ESR, LDH
normocytic anaemia
LDH guides volume of disease
test for HIV
biopsy: reed sternberg

ABVD
BEACOPP
autologous SCT
adjuvant RTX for stage I or II

38
Q

lung cancer treatment

A

NSCLC:
CTX for stage 2/3 or not suitable for surgery
RX if surgery not suitable or can’t tolerate CTX

ablation for primary and secondary lung ca
photodynamic therapy for localised inoperable endobronchial ca

SCLC:
surgery for early stage
CTX +/- RTX for limited stage
CTX for extensive stage
repeat CTX for recurrence
RTX for palliation

39
Q

lung ca paraneoplastic syndromes

A

SCLC: lambert eaton, ACTH, SIADH

squamous: PTH and bony mets, TSH

large cell: gynaecomastia
adenocarcinoma: gynaecomastia, HPOA- periostitis, clubbing, arthritis

40
Q

BRCA1 and 2

A

BRCA1: chr 17 long arm, auto dom. assoc w/ female breast, ovarian, prostate, colon

BRCA2: chr 13 long arm. assoc w/ breast, ovarian

41
Q

indications for CTX for breast ca

A

premenopausal
lymph node positive
ER negative
grade III
large tumour
lymphovascular invasion

benefits of neoadjuvant:
monitor response and optimise CTx regime
reduce size to allow breast conserving surgery

42
Q

indications for mastectomy

A

> 4cm or multifocal or central

43
Q

NHL treatment

A

CHOP or FCR CTX
MTX + dex for primary CNS lymphoma

44
Q

pancreatic cancer treatment

A

neoadjuvant chemo if borderline resectable
adjuvant gemcitabine + capecitabine
folfirinox or gemcitabine or oxiplatin for metastatic

45
Q

peutz jeghers

A

auto dom STK11 chr 19
perioral and mucosal pigmentation
GI hamartomatous polyps
GI, pancreas, lung, breast, thyroid, uterus, ovaries, testes malignancy
2 yearly colonoscopy > 25y

46
Q

prostate ca diagnosis

A

transrectal ultrasound with 10-12 random biopsies
MRI for staging

47
Q

prostate ca staging

A

T1- clinically unapparent
T1a- incidental finding at TURP
T1b- incidental at TURP, > %5 tissue resected
T1c- identified on biopsy due to PSA
T2- palpable, confined to prostate
T2a- half a lobe or less
T2b- > half a lobe
T2c- both lobes
T3 extracapsular extension
T4 adjacent structures beyond seminal vesicles

Gleason grading 2 areas out of 5

48
Q

prostate ca treatment

A

T1 and 2 potentially curable
T3 and 4 considered advanced

radical RTX or prostatectomy
antiandrogens
LHRH antagonists

49
Q

types of testicular ca

A

seminomas:
homogenous macroscopic appearance
sheets of clear cells
classic, anaplastic and spermatocytic

non seminoma GCT:
embryonal- glands or papules
yolk sac- schiller duval (look like glomeruli)
choriocarcinoma- look like cytotrophoblasts
teratoma
most have mixed pattern

stromal tumours and lymphomas

50
Q

testicular tumour markers

A

AFP (non seminomas)
BHCG (mostly non seminomas)
LDH (non specific)
PLAP (seminomas)

51
Q

testicular ca treatment

A

radical orchidectomy
metastatic NSGCT: BEP CTX, resect residual masses
seminoma: carboplatin single dose post op
seminoma w/ mets: RTX +/- CTX

52
Q

tumour lysis syndrome

A

raised urea, potassium, phosphate
tx:
IV fluids
allopurinol (won’t treat hyperuricaemia)
urate oxidase (to treat hyperuricaemia)
sodium bicarb
calcium
dialysis
febuxostat

53
Q

NSE tumour marker

A

SCLC
neuroblastoma

54
Q

ca 19-9 cancers

A

pancreas
bowel
lung
gall bladder